Dow Jones U.S. Pharmaceuticals Index


D.J. US Pharmaceutical Top 10: Value Investment Strategy

TOP 10 Value VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Prestige (L, US)  Pharmaceuticals
1. Prestige (L, US)   Pharmaceuticals 79 60 30 80
2. Pfizer (XXL, US)  Pharmaceuticals
2. Pfizer (XXL, US)   Pharmaceuticals 75 30 22 27
3. Phibro Animal (L, US)  Pharmaceuticals
3. Phibro Animal (L, US)   Pharmaceuticals 67 22 32 29
4. Lannett (M, US)  Pharmaceuticals
4. Lannett (M, US)   Pharmaceuticals 51 60 36 70
5. Catalent (L, US)  Pharmaceuticals
5. Catalent (L, US)   Pharmaceuticals 41 83 45 100

June 8, 2018. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Growth Investment Strategy

TOP 10 Growth VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Supernus Pharma (M, US)   Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals 7 100 82 100
2. Nektar (L, US)   Pharmaceuticals
2. Nektar (L, US)   Pharmaceuticals 1 100 12 22
3. AbbVie (XXL, US)   Biotechnology
3. AbbVie (XXL, US)   Biotechnology 26 97 5 27
4. Catalent (L, US)   Pharmaceuticals
4. Catalent (L, US)   Pharmaceuticals 41 83 45 100
5. Eli Lilly (XXL, US)   Pharmaceuticals
5. Eli Lilly (XXL, US)   Pharmaceuticals 19 61 33 22
6. Zoetis (XL, US)   Pharmaceuticals
6. Zoetis (XL, US)   Pharmaceuticals 21 61 26 20
7. Prestige (L, US)   Pharmaceuticals
7. Prestige (L, US)   Pharmaceuticals 79 60 30 80

June 8, 2018. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Safety Investment Strategy

TOP 10 Safety VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Supernus Pharma (M, US)   Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals 7 100 82 100
2. Pacira BioSciences (M, US)   Pharmaceuticals
2. Pacira BioSciences (M, US)   Pharmaceuticals 5 33 50 33
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals
3. Bristol-Myers Squibb (XXL, US)   Pharmaceuticals 10 40 49 16
4. Catalent (L, US)   Pharmaceuticals
4. Catalent (L, US)   Pharmaceuticals 41 83 45 100
5. Johnson & Johnson (XXL, US)   Pharmaceuticals
5. Johnson & Johnson (XXL, US)   Pharmaceuticals 17 40 38 16

June 8, 2018. Top 10s are published weekly by . ()


D.J. US Pharmaceutical Top 10: Combined Investment Strategy

TOP 10 Combined VALUEVVV GROWTHVV SAFETYVV COMBINED
1. Supernus Pharma (M, US)   Pharmaceuticals
1. Supernus Pharma (M, US)   Pharmaceuticals 7 100 82 100
2. Catalent (L, US)   Pharmaceuticals
2. Catalent (L, US)   Pharmaceuticals 41 83 45 100
3. Prestige (L, US)   Pharmaceuticals
3. Prestige (L, US)   Pharmaceuticals 79 60 30 80
4. Lannett (M, US)   Pharmaceuticals
4. Lannett (M, US)   Pharmaceuticals 51 60 36 70
5. Pacira BioSciences (M, US)   Pharmaceuticals
5. Pacira BioSciences (M, US)   Pharmaceuticals 5 33 50 33

June 8, 2018. Top 10s are published weekly by . ()

This company has a special achievement which is documented on its stock research page.

Top 10 lists may contain fewer than 10 stocks due to Obermatt’s top 10 quality standards.

Top 10 Stocks from the purely finance fact-based Obermatt Method for the investment strategies Value, Growth and Safety in the stock index Dow Jones U.S. Pharmaceuticals Index from June 8, 2018.

Top 10 Stock History D.J. US Pharmaceutical



We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.

Register for
stock tips now


Stock investing made easy